Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015
ORIGINAL RESEARCH — Volume 14 — September 28, 2017
PEER REVIEWED
Figures 1a–d.
Percentage of Wisconsin stakeholder organizations (N = 117) reporting activities to increase human papillomavirus vaccination in Wisconsin, 2013–2015. Figure 1a shows stakeholder organizations with activities focused on adolescents and parents, 1b shows stakeholder organizations with activities focused on clinical and health professionals, 1c shows stakeholder organizations with activities focused on communities and health systems, and 1d shows stakeholder organizations with activities focused on advocacy and public policy. The rates of advocating for public policy change and advocating for increased public funding increased over time (P < .05).
| Stakeholder Target Audience | 2013 | 2014 | 2015 |
|---|---|---|---|
| Activity Rate, % | |||
| 1a. Adolescents and parents | |||
| Printed educational materials | 46.2 | 58.1 | 69.2 |
| One-on-one consultations | 41.0 | 48.7 | 54.7 |
| Reminders of vaccination | 26.5 | 38.5 | 47.9 |
| Referrals to vaccination services | 32.5 | 44.4 | 46.2 |
| 1b. Clinical and health professionals | |||
| Printed educational materials | 28.2 | 41.9 | 53.0 |
| Professional education | 19.7 | 40.2 | 47.0 |
| Protocols to track and report vaccination rates | 13.7 | 20.5 | 35.0 |
| Website focused on health professionals | 4.3 | 5.1 | 11.1 |
| 1c. Communities and health systems | |||
| Community events or health fairs | 6.0 | 22.2 | 21.4 |
| Media campaigns to raise awareness | 6.8 | 25.6 | 39.3 |
| Community committees or work groups | 10.3 | 16.2 | 24.8 |
| Funding and promotion | 12.0 | 17.9 | 23.1 |
| 1d. Advocacy and public policy | |||
| Advocate public policy change | 5.1 | 7.7 | 14.5 |
| Advocate for increasing public funding for vaccination | 3.4 | 5.1 | 11.1 |
| Advocate for increasing public funding for research | 2.6 | 2.6 | 4.3 |
Figures 2a–d.
Percentage of Wisconsin stakeholder organizations (N = 117) reporting barriers to human papillomavirus (HPV) vaccination, from 2013 through 2015. Figure 2a shows percentage of stakeholder organizations reporting barriers related to adolescents and parents (n = 75), 2b shows the percentage of stakeholder organizations reporting barriers related to clinical and health professionals (n = 54), 2c shows the percentage of stakeholder organizations reporting barriers related to communities and health systems (n = 43), and 2d shows the percentage of stakeholder organizations reporting barriers related to advocacy and public policy (n = 10). Abbreviation: STI, sexually transmitted infection.
| Category | % |
|---|---|
| 2a. Adolescents and parents, n = 75 | |
| Lack of education | 86.6 |
| Logistical barriers | 74.7 |
| Deferred vaccination | 71.7 |
| Belief that adolescent is not at risk | 71.6 |
| Belief that child is too young | 68.5 |
| 2b. Clinical and health professionals, n = 54 | |
| Ensure the completion of 3 doses | 63.0 |
| Concern that parents will decline | 57.7 |
| Reluctance to discuss sexuality or STIs | 45.3 |
| Concern about time to discuss the vaccine | 41.5 |
| HPV vaccination not required for school attendance | 37.1 |
| 2c. Communities and health systems, n = 43 | |
| Lack of education | 44.1 |
| Ensure the completion of 3 doses | 41.9 |
| Belief that child is too young | 41.8 |
| Lack of information | 39.5 |
| Reluctance to discuss sexuality or STIs | 38.7 |
| 2d. Advocacy and public policy, n = 10 | |
| Lack of provider recommendation | 70.0 |
| Concerns about vaccine safety | 60.0 |
| Reluctance to discuss sexuality or STIs | 60.0 |
| Lack of information | 50.0 |
| Lack of education | 50.0 |
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.